FDA approves Lanett’s muscle relaxant drug: 3 things to know

The Food and Drug Administration approved Philadelphia-based Lannett’s metaxalone tablets.

Advertisement

Here are three things to know.

1. The drug is a muscle relaxant intended to treat patients with acute, painful musculoskeletal conditions.

2. Metaxalone tablets are a generic version of King Pharmaceuticals’ drug Skelaxin.

3. Lannett plans to launch the drug this quarter.

More articles on supply chain:

Court orders contracted pilots for Amazon, DHL to return to work after strike
Medisafe and TimerCap launch Bluetooth-enabled pill bottle to track medication adherence
Demand for durable manufactured goods rose 4.8% in October — largest jump in a year

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.